Chronic lung fibrosis following carmustine (BCNU) chemotherapy: Radiological featuresCitation formats

  • Authors:
  • P. M. Taylor
  • B. R. O'Driscoll
  • H. R. Gattamaneni
  • A. A. Woodcock

Standard

Chronic lung fibrosis following carmustine (BCNU) chemotherapy: Radiological features. / Taylor, P. M.; O'Driscoll, B. R.; Gattamaneni, H. R.; Woodcock, A. A.

In: Clinical Radiology, Vol. 44, No. 5, 11.1991, p. 299-301.

Research output: Contribution to journalArticle

Harvard

Taylor, PM, O'Driscoll, BR, Gattamaneni, HR & Woodcock, AA 1991, 'Chronic lung fibrosis following carmustine (BCNU) chemotherapy: Radiological features' Clinical Radiology, vol. 44, no. 5, pp. 299-301.

APA

Taylor, P. M., O'Driscoll, B. R., Gattamaneni, H. R., & Woodcock, A. A. (1991). Chronic lung fibrosis following carmustine (BCNU) chemotherapy: Radiological features. Clinical Radiology, 44(5), 299-301.

Vancouver

Taylor PM, O'Driscoll BR, Gattamaneni HR, Woodcock AA. Chronic lung fibrosis following carmustine (BCNU) chemotherapy: Radiological features. Clinical Radiology. 1991 Nov;44(5):299-301.

Author

Taylor, P. M. ; O'Driscoll, B. R. ; Gattamaneni, H. R. ; Woodcock, A. A. / Chronic lung fibrosis following carmustine (BCNU) chemotherapy: Radiological features. In: Clinical Radiology. 1991 ; Vol. 44, No. 5. pp. 299-301.

Bibtex

@article{666042e2b9e84c998f31b19d9abe232b,
title = "Chronic lung fibrosis following carmustine (BCNU) chemotherapy: Radiological features",
abstract = "Carmustine (BCNU) is a cytotoxic drug which is a recognized cause of acute pulmonary fibrosis. We describe the radiological findings in six patients who received carmustine in childhood for treatment of central nervous system tumours and were subsequently found to have pulmonary fibrosis 13-17 years after treatment. Patients were studied by chest radiography and high resolution computed tomography. The pattern of disease is novel, involving the upper zones in a predominantly peripheral pattern. {\circledC} 1991 The Royal College of Radiologists. All rights reserved.",
author = "Taylor, {P. M.} and O'Driscoll, {B. R.} and Gattamaneni, {H. R.} and Woodcock, {A. A.}",
year = "1991",
month = "11",
language = "English",
volume = "44",
pages = "299--301",
journal = "Clinical Radiology",
issn = "0009-9260",
publisher = "W.B. Saunders Co. Ltd.",
number = "5",

}

RIS

TY - JOUR

T1 - Chronic lung fibrosis following carmustine (BCNU) chemotherapy: Radiological features

AU - Taylor, P. M.

AU - O'Driscoll, B. R.

AU - Gattamaneni, H. R.

AU - Woodcock, A. A.

PY - 1991/11

Y1 - 1991/11

N2 - Carmustine (BCNU) is a cytotoxic drug which is a recognized cause of acute pulmonary fibrosis. We describe the radiological findings in six patients who received carmustine in childhood for treatment of central nervous system tumours and were subsequently found to have pulmonary fibrosis 13-17 years after treatment. Patients were studied by chest radiography and high resolution computed tomography. The pattern of disease is novel, involving the upper zones in a predominantly peripheral pattern. © 1991 The Royal College of Radiologists. All rights reserved.

AB - Carmustine (BCNU) is a cytotoxic drug which is a recognized cause of acute pulmonary fibrosis. We describe the radiological findings in six patients who received carmustine in childhood for treatment of central nervous system tumours and were subsequently found to have pulmonary fibrosis 13-17 years after treatment. Patients were studied by chest radiography and high resolution computed tomography. The pattern of disease is novel, involving the upper zones in a predominantly peripheral pattern. © 1991 The Royal College of Radiologists. All rights reserved.

M3 - Article

VL - 44

SP - 299

EP - 301

JO - Clinical Radiology

JF - Clinical Radiology

SN - 0009-9260

IS - 5

ER -